SCHEMBL19877232

SCHEMBL19877232

[CH2]c1ccccc1CCCCCCCCCCC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 1/20 0.58
THRA P10827 1/20 0.47
THRB P10828 1/20 0.47
NR1H2 P55055 1/20 0.47
NR1H3 Q13133 1/20 0.47
BID P55957 3/20 0.45
MCL1 Q07820 3/20 0.45
BCL2L1 Q07817 2/20 0.45
BAK1 Q16611 2/20 0.45
KAT8 Q9H7Z6 2/20 0.45
PPARG P37231 1/20 0.45
PPARA Q07869 1/20 0.45
EP300 Q09472 1/20 0.45
KAT2A Q92830 1/20 0.45
KAT2B Q92831 1/20 0.45
KAT5 Q92993 1/20 0.45
SAE1 Q9UBE0 1/20 0.45
KCNH2 Q12809 2/20 0.44
ALOX5 P09917 2/20 0.43
PTGS2 P35354 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL375253 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL395649 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL10809003 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL5487867 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL139445 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL11369508 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL396330 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL7338375 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL7170683 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3
SCHEMBL396013 1.00 LIPG (0.58) LIPGTHRATHRBNR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3992288-A1 CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME BioNTech Delivery Technologies GmbH (DE) 2022-05-04 EP disclosed
EP-3500673-B1 CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME BIONTECH DELIVERY TECH GMBH (DE) 2021-10-06 EP disclosed
US-10894962-B2 Carboxylated 2′-amino-LNA nucleotides and oligonucleotides comprising the same BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2021-01-19 US disclosed
US-20190203208-A1 CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) 2019-07-04 US disclosed
EP-3500673-A1 CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME Panzner, Steffen (DE) 2019-06-26 EP disclosed
WO-2018033492-A1 CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME PANZNER STEFFEN (DE) 2018-02-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190203208-A1 CARBOXYLATED 2'-AMINO-LNA NUCLEOTIDES AND OLIGONUCLEOTIDES COMPRISING THE SAME DCTD, NSUN2, SLC29A2 LIPG 3374/4885THRA 2588/4885THRB 3192/4885
US-10894962-B2 Carboxylated 2′-amino-LNA nucleotides and oligonucleotides comprising the same DCTD, NSUN2, TRDMT1 LIPG 3188/4885THRA 2512/4885THRB 3192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.